Support The THOR Network Foundation

As an alloimmunized mother, I know firsthand how overwhelming and terrifying this condition can be. During my first alloimmunized pregnancy I realized that I had to navigate a very complex medical landscape by myself and I felt very let down by my medical community. That’s why the work of the THOR Network means so much to me and many other women facing similar challenges. I’ve been so impressed by their commitment to improving healthcare practices for alloimmunized mothers and their children. They not only provide cutting-edge research and best practices but also demonstrate genuine compassion for the unique struggles we face. They go out of their way to ensure that providers understand the importance of early screening and advanced care for HDFN, making a real difference in the lives of families like mine. Through the THOR Network’s dedication, I feel hopeful that more women will receive the care they deserve, and that fewer babies will face the risks of HDFN. I am deeply grateful for their tireless work and their unwavering support in advocating for us.

The THOR network has been an integral part of our Foundation’s reach and impact. THOR is dedicated to women’s healthcare issues related to severe bleeding and improving outcomes for pregnant women and families. THOR has amplified our own mission to reduce harm and death due to hemolytic disease of the fetus and newborn (HDFN) through dissemination of materials, speaking opportunities, and exposure to clinicians and decision makers who share our commitment to improving human health with a patient-centered perspective. We look forward to many years of continued partnership.

The THOR Network translates key lessons learned from combat casualties to the seriously injured civilian. A prime example is the return to in-hospital resuscitation with whole blood, and additionally extended to prehospital care. The broader use of prehospital tourniquets and TXA, and introduction of REBOA are other compelling examples. The core Network represents diverse viewpoints of military and civilian providers, including prehospital, emergency department, surgery, and critical care. This environment is enriched with basic investigators expert in resuscitation physiology and coagulation biology. The audience also includes virtually all relevant funding agencies, including NIH, DOD, BARDA, and industry.

THOR has been a key driving force in improving the methods and capabilities used to resuscitate bleeding military and civilian casualties. Much more than just another conference, from promulgating the results of persuasive bench research, to facilitating interactions between blood suppliers and clinicians that have led to capability development and regulatory reform, to developing training materials for Emergency Blood Collection used by numerous partner nations, THOR has been a major force in reducing mortality from life-threatening haemorrhage.

THOR has been integral as a platform for communication between military and civilian trauma and to help the trauma research community understand the rapidly evolving priorities in military medicine. Also, THOR has admirably spread the science of resuscitation after injury and led an international dialogue about best practices in trauma resuscitation. This has shaped research priorities for my program and many others.  We greatly appreciate the resources and opportunities created by the THOR Network.

Since its foundation more than a decade ago, THOR has continued to drive and advocate for innovation in trauma care and transfusion medicine. Their collaborative and persistent spirit fuels synergy between medical experts, government institutions, and the biotech/med tech industry, which is unique. A determined focus on the ready availability of safe and effective treatments for life-threatening bleeding in both civilian and military settings is having a lasting impact

The disruptive and revolutionary effects of this passionate and purposeful Network have truly driven international change in both military and civilian prehospital resuscitative care.